| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $794.2M | +28.0% |
| R&D Expense | $160.4M | +6.0% |
| SG&A Expense | $86.0M | -8.0% |
| Operating Income | $135.6M | — |
| Pre-tax Income | $150.3M | +1779.7% |
| Income Tax | -$53.7M | -1115.0% |
| Net Income | $204.1M | +7452.5% |
| EPS (Basic) | $5.63 | +6937.5% |
| EPS (Diluted) | $5.55 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $42.5M | -14.1% |
| Accounts Receivable | $24.3M | +17.6% |
| Current Assets | $335.4M | +23.1% |
| Total Assets | $626.7M | +53.3% |
| Current Liabilities | $63.3M | -9.3% |
| Total Liabilities | $107.4M | -3.8% |
| Stockholders' Equity | $519.3M | +74.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $188.2M | +212.1% |
| Capital Expenditures | $2.0M | -77.7% |
| Investing Cash Flow | -$151.8M | -173.0% |
| Financing Cash Flow | -$43.4M | -67.2% |
| Free Cash Flow | $186.1M | +263.3% |
| +7828.6% |